Clinical Trial Update: Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB) [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating BAY1817080 for safety and treatment effect in adults with Overactive Bladder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• BAY1817080

Snippet

Sponsor: Bayer | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED